ArticleDiscover oncology2025

Mendelian randomization analysis reveals potential causal relationships between serum lipid metabolites and prostate cancer risk.

Chuanmin Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.